No difference in mortality risk seen for GLP-1 RA and SGLT2i users; significantly lower risk seen for GLP-1 RA versus DPP4i users.

Researchers conducted a concept analysis of processing speed in relation to the cognitive function of patients with cancer.

In the APOLLO trial, first-line treatment with anlotinib plus penpulimab improved progression-free survival and overall survival when compared to sorafenib.

A PedCST designed for pediatric oncology nurses and an interactive e-picture book application for pediatric patients and their parents improved QOL and emotional well-being for children with cancer.

The authors concluded that even mild 18 F-FDG uptake may indicate the presence of lymphoma in areas of the brain where the blood-brain barrier is intact. They recommended clinicians be suspicious of ...

The supplemental Biologics License Application for the gastric/GEJ cancer indication is supported by data from the double-blind, placebo-controlled MATTERHORN trial.

These findings suggest a need to investigate whether age-specific trends are due to guidelines that suggest reduced screening for older age groups,” the researchers wrote.

Topline data were announced from a phase 3 trial evaluating zanzalintinib in combination with atezolizumab in patients with previously treated non-microsatellite instability (MSI)-high metastatic ...

Our trial provides proof of concept that cytokine-armored CAR T-cell treatment is feasible and may enhance antitumor activity without additional toxic effects,” researchers reported.

Robot-assisted laparoscopic supratrigonal cystectomy with augmentation cystoplasty is feasible, with acceptable complication rates.

A retrospective assessment of patient records identified common oral complications of radiotherapy and chemoradiotherapy for head and neck cancers.

HealthDay News — Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study published online July 21 in ...